Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma
by on Friday, July 13th, 2012 | No Comments
Condition: Metastatic Colorectal Adenocarcinoma
Interventions: Drug: Gemcitabine; Drug: Docetaxel; Drug: Filgrastim or Pegfilgrastim
Sponsors: Sidney Kimmel Comprehensive Cancer Center; Sidney Kimmel Comprehensive Cancer Center
Not yet recruiting – verified July 2012
View original post here: Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma